FINALS (OSTEOPOROSIS)

    Cards (35)

    • What is osteoporosis?
         - a) A condition where bones become weak and brittle
         - b) A condition where bones become overly dense
         - c) A condition where bones become inflamed
         - d) A condition where bones become infected
      A
    • Which demographic is at higher risk for osteoporosis?
         - a) Asian and Caucasian female patients
         - b) African male patients
         - c) Young children
         - d) Pregnant women
      A.
    • What are common sites for osteoporosis-related fractures?
         - a) Hip, wrist, and spine
         - b) Shoulder, knee, and ankle
         - c) Elbow, fingers, and toes
         - d) Skull, ribs, and pelvis
      A.
    • List three potential symptoms of osteoporosis.
      Back pain, loss of height, stooped posture, bones that breaks easily
    • What happens when bone resorption exceeds bone formation?
         - a) Bone mass increases
         - b) Bone mass remains stable
         - c) Bone mass decreases
         - d) Bone mass fluctuates
      C
    • When do men and women typically begin to lose bone mass?
         - a) Second decade
         - b) Third or fourth decade
         - c) Fifth or sixth decade
         - d) Seventh or eighth decade
      B.
    • How does estrogen deficiency during menopause affect bone health?
         - a) Decreases osteoclast activity
         - b) Increases osteoclast activity
         - c) Increases osteoblast activity
         - d) Decreases osteoblast activity
      B.
    • Name two common contributing factors to male osteoporosis.
      Secondary cause & ageing
    • What effect do glucocorticoids have on bone formation?
         - a) Increase proliferation and differentiation of osteoblasts
         - b) Decrease proliferation and differentiation of osteoblasts
         - c) Increase calcium absorption
         - d) Decrease bone resorption
      B.
    • At what oral dose of prednisone or equivalent daily have fractures been associated?
          - a) 1.0 mg
          - b) 2.5 mg
          - c) 5.0 mg
          - d) 10.0 mg
      B.
    • What are the risk factors listed by the World Health Organization (WHO) to predict the percent probability of fracture in the next 10 years? (Select all that apply)
         - a) Age
         - b) Race/ethnicity
         - c) Blood type
         - d) Sex (gender)
         - e) Previous fragility fracture
         - f) Parent history of hip fracture
         - g) Body mass index
         - h) Glucocorticoid use
         - i) Smoking & alcohol use (three or more drinks per day)
         - j) Rheumatoid arthritis
         - k) Select secondary causes
      A, B, D, E, F, H, I, J, K
    • Which of the following is NOT a physical examination finding associated with osteoporosis?
         - a) Bone pain
         - b) Postural changes (ie, kyphosis)
         - c) Loss of height (>1.5 in [3.8 cm])
         - d) Increased muscle mass
      D.
    • What is the diagnostic standard for measuring bone mineral density (BMD)?
         - a) Blood test
         - b) Dual-energy X-ray absorptiometry (DXA) of the hip and spine
         - c) MRI
         - d) Ultrasound of the forearm
      B.
    • What does a T-score at or below -2.5 indicate?
         - a) Normal bone mass
         - b) Osteopenia (low bone mass)
         - c) Osteoporosis
         - d) Hypercalcemia
      C.
    • . What laboratory tests are commonly performed in the diagnosis of osteoporosis? (Select all that apply)
         - a) Complete blood count (CBC)
         - b) Creatinine
         - c) Blood urea nitrogen (BUN)
         - d) Calcium
         - e) Phosphorus
         - f) Alkaline phosphatase
         - g) Albumin
         - h) Thyroid-stimulating hormone (TSH)
         - i) Free testosterone
         - j) 25-hydroxyvitamin D
         - k) 24-hour urine concentrations of calcium and phosphorus
      ALL
    • What are the goals of treatment in patients with osteoporosis? (Select all that apply)
         - a) Stabilize or improve bone mass and strength
         - b) Prevent fractures
         - c) Increase blood pressure
         - d) Improve function and quality of life
      A, B, D
    • Which dietary element is important for individuals with osteoporosis to maintain?
         - a) High sodium intake
         - b) High cholesterol intake
         - c) Adequate calcium and vitamin D intake
         - d) High sugar intake
      C.
    • How can you calculate the amount of calcium in a food serving?
         - a) Multiply the percentage of the daily value by 10
         - b) Add a zero to the percentage of the daily value on food labels
         - c) Divide the percentage of the daily value by 2
         - d) Subtract the percentage of the daily value from 100
      B.
    • What is the recommended maximum alcohol consumption for women with osteoporosis?
         - a) One drink per day
         - b) Two drinks per day
         - c) Three drinks per day
         - d) Four drinks per day
      A.
    • What type of exercise is beneficial for individuals with osteoporosis?
          - a) Weight-bearing aerobic and strengthening exercises
          - b) High-impact sports
          - c) Prolonged bed rest
          - d) Swimming only
      A.
    • What is the maximum recommended single dose of elemental calcium to ensure proper absorption?
         - a) 200 mg
         - b) 400 mg
         - c) 600 mg
         - d) 800 mg
      C.
    • Which form of calcium should be ingested with meals to enhance absorption in an acidic environment?
         - a) Calcium citrate
         - b) Calcium carbonate
         - c) Tricalcium phosphate
         - d) Calcium sulfate
      B.
    • What is a potential benefit of calcium citrate over calcium carbonate?
         - a) Higher concentration of elemental calcium
         - b) Less expensive
         - c) Fewer gastrointestinal side effects
         - d) Requires acidic environment for absorption
      C.
    • How does vitamin D supplementation aid in the treatment of osteoporosis?
         - a) Decreases bone resorption
         - b) Maximizes intestinal calcium absorption and BMD
         - c) Increases phosphorus absorption
         - d) Reduces muscle mass
      B.
    • . What is the effect of bisphosphonates on bone mineral density (BMD) and fracture risk?
         - a) Decrease BMD and increase fracture risk
         - b) Increase BMD and reduce fracture risk
         - c) No effect on BMD or fracture risk
         - d) Increase fracture risk without affecting BMD
      B.
    • Which bisphosphonates are indicated for postmenopausal, male, and glucocorticoid-induced osteoporosis?
         - a) Alendronate, risedronate, and IV zoledronic acid
         - b) Alendronate and oral ibandronate
         - c) IV ibandronate and risedronate
         - d) Zoledronic acid and oral ibandronate
      A.
    • What is the mechanism of action of denosumab (Prolia)?
         - a) Increases osteoclast activity
         - b) Inhibits osteoclast formation and increases osteoclast apoptosis
         - c) Decreases bone resorption by osteoblasts
         - d) Increases calcium absorption in the gut
      B.
    • How often is denosumab administered for osteoporosis treatment?
         - a) Daily
         - b) Weekly
         - c) Monthly
         - d) Every six months
      D.
    • What is the black box warning associated with raloxifene?
         - a) Risk of liver disease
         - b) Risk of kidney failure
         - c) Risk of stroke in women at risk
         - d) Risk of heart attack
      C.
    • Why is salmon calcitonin preferred over its mammalian form for osteoporosis treatment?
          - a) It is cheaper
          - b) It is more potent and longer lasting
          - c) It has fewer side effects
          - d) It is easier to administer
      B.
    • What is the recommended intranasal dose of calcitonin for osteoporosis treatment?
          - a) 100 units daily
          - b) 200 units daily, alternating nares every other day
          - c) 300 units weekly
          - d) 400 units monthly
      B.
    • What happens to bone mass and fracture protection when estrogen therapy is discontinued?
          - a) Bone mass increases, and fracture protection is enhanced
          - b) Bone loss accelerates, and fracture protection is lost
          - c) Bone mass remains the same, and fracture protection remains
          - d) Bone mass and fracture protection are unaffected
      B.
    • For how long is teriparatide (Forteo) approved for use in osteoporosis treatment?
          - a) 6 months
          - b) 1 year
          - c) 2 years
          - d) 5 years
      C.
    • What is the daily dose of teriparatide, and where is it administered?
          - a) 10 mcg subcutaneously in the upper arm
          - b) 20 mcg subcutaneously in the thigh or abdomen
          - c) 30 mcg subcutaneously in the hip
          - d) 40 mcg subcutaneously in the upper arm or thigh
      B.
    • How often should central DXA BMD measurements be obtained after initiating osteoporosis medication to monitor response?
          - a) Every 6 months
          - b) Every 1 to 2 years
          - c) Every 3 to 4 years
          - d) Every 5 years
      B.